{"Symbol": "ACTU", "AssetType": "Common Stock", "Name": "Actuate Therapeutics, Inc. Common stock", "Description": "Actuate Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with underserved medical needs, particularly in cancer and other serious diseases. The company is advancing its proprietary drug candidates through rigorous clinical trials, targeting mechanisms that could significantly improve patient outcomes. With a strong emphasis on delivering novel therapies, Actuate aims to address critical gaps in existing treatment paradigms and foster a robust pipeline that promises both strategic growth and value creation for investors. As it progresses through various stages of development, Actuate stands poised to make a meaningful impact in the biotechnology sector.", "CIK": "1652935", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "BIOTECHNOLOGY", "Address": "1751 RIVER RUN, FORT WORTH, TX, UNITED STATES, 76107", "OfficialSite": "https://actuatetherapeutics.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-06-30", "MarketCapitalization": "136671000", "EBITDA": "None", "PERatio": "None", "PEGRatio": "None", "BookValue": "-0.13", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-3.11", "RevenuePerShareTTM": "0", "ProfitMargin": "0", "OperatingMarginTTM": "0", "ReturnOnAssetsTTM": "-3.49", "ReturnOnEquityTTM": "0", "RevenueTTM": "0", "GrossProfitTTM": "0", "DilutedEPSTTM": "-3.11", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0", "AnalystTargetPrice": "26.75", "AnalystRatingStrongBuy": "0", "AnalystRatingBuy": "4", "AnalystRatingHold": "0", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "-", "ForwardPE": "-", "PriceToSalesRatioTTM": "-", "PriceToBookRatio": "9.2", "EVToRevenue": "-", "EVToEBITDA": "-", "Beta": "None", "52WeekHigh": "11.99", "52WeekLow": "4.04", "50DayMovingAverage": "7.07", "200DayMovingAverage": "7.77", "SharesOutstanding": "23243300", "SharesFloat": "8398900", "PercentInsiders": "16.144", "PercentInstitutions": "49.726", "DividendDate": "None", "ExDividendDate": "None"}